Home › NDC Lookup › Labelers › U.s. Pharmaceuticals

U.s. Pharmaceuticals NDCs and Package Codes

This page lists NDC package records associated with labeler code 63539 (U.s. Pharmaceuticals) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

23
Package NDCs
38
Products
37
Active listings
1
Discontinued
11
Ingredients
0
Therapeutic classes
7
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
tofacitinib 10
abrocitinib 9
palbociclib 6
talazoparib 4
axitinib 2
conjugated estrogens/bazedoxifene 2
zavegepant 1
Bosutinib 1
elranatamab-bcmm 1
ritlecitinib 1
By dosage form
TABLET, FILM COATED 25
TABLET, EXTENDED RELEASE 4
CAPSULE 3
CAPSULE, LIQUID FILLED 2
SOLUTION 2
SPRAY 1
INJECTION, SOLUTION 1

Browse records — 38 products

Drug / product Billing NDC NADAC / unit Status
BOSULIF Bosutinib 400 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0193-30 · 30 TABLET, FILM COATED in 1 BOTTLE (63539-193-30) 63539-0193-30 — On market View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — On market View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — On market View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — On market View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — On market View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — On market View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — On market View →
CIBINQO abrocitinib 50 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0236-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) 63539-0236-14 — On market View →
CIBINQO abrocitinib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0336-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) 63539-0336-14 — On market View →
CIBINQO abrocitinib 200 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0436-14 · 14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) 63539-0436-14 — On market View →
Duavee conjugated estrogens/bazedoxifene .45 mg/1; 20 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0122-07 · 1 BLISTER PACK in 1 CARTON (63539-122-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 63539-0122-07 — On market View →
Duavee conjugated estrogens/bazedoxifene .45 mg/1; 20 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0122-07 · 1 BLISTER PACK in 1 CARTON (63539-122-07) / 7 TABLET, FILM COATED in 1 BLISTER PACK 63539-0122-07 — On market View →
Elrexfio elranatamab-bcmm 44 mg/1.1mL INJECTION, SOLUTION U.S. · NDC 63539-0252-02 · 1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01) 63539-0252-02 — On market View →
Ibrance palbociclib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0486-03 · 3 DOSE PACK in 1 CARTON (63539-486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-486-07) 63539-0486-03 — On market View →
Ibrance palbociclib 75 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0284-03 · 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07) 63539-0284-03 — On market View →
Ibrance palbociclib 125 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0688-03 · 3 DOSE PACK in 1 CARTON (63539-688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-688-07) 63539-0688-03 — On market View →
Ibrance palbociclib 125 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0688-03 · 3 DOSE PACK in 1 CARTON (63539-688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-688-07) 63539-0688-03 — On market View →
Ibrance palbociclib 75 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0284-03 · 3 DOSE PACK in 1 CARTON (63539-284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-284-07) 63539-0284-03 — On market View →
Ibrance palbociclib 100 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0486-03 · 3 DOSE PACK in 1 CARTON (63539-486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (63539-486-07) 63539-0486-03 — On market View →
INLYTA axitinib 1 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0026-01 · 90 TABLET, FILM COATED in 1 BOTTLE (63539-026-01) 63539-0026-01 — On market View →
INLYTA axitinib 5 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0044-01 · 60 TABLET, FILM COATED in 1 BOTTLE (63539-044-01) 63539-0044-01 — Discontinued View →
Litfulo ritlecitinib 50 mg/1 CAPSULE U.S. · NDC 63539-0334-28 · 28 CAPSULE in 1 BOTTLE (63539-334-28) 63539-0334-28 — On market View →
Lorbrena lorlatinib 25 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0927-01 · 30 TABLET, FILM COATED in 1 BOTTLE (63539-927-01) 63539-0927-01 — On market View →
Talzenna talazoparib .5 mg/1 CAPSULE, LIQUID FILLED U.S. · NDC 63539-0025-30 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-025-30) 63539-0025-30 — On market View →
Talzenna talazoparib 1 mg/1 CAPSULE U.S. · NDC 63539-0295-30 · 1 BOTTLE in 1 CARTON (63539-295-30) / 30 CAPSULE in 1 BOTTLE 63539-0295-30 — On market View →
Talzenna talazoparib 1 mg/1 CAPSULE, LIQUID FILLED U.S. · NDC 63539-0031-30 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-031-30) 63539-0031-30 — On market View →
Talzenna talazoparib .5 mg/1 CAPSULE U.S. · NDC 63539-0051-30 · 1 BOTTLE in 1 CARTON (63539-051-30) / 30 CAPSULE in 1 BOTTLE 63539-0051-30 — Discontinued View →
XELJANZ tofacitinib 5 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0012-02 · 60 TABLET, FILM COATED in 1 BOTTLE (63539-012-02) 63539-0012-02 — On market View →
XELJANZ tofacitinib 10 mg/1 TABLET, FILM COATED U.S. · NDC 63539-0016-02 · 60 TABLET, FILM COATED in 1 BOTTLE (63539-016-02) 63539-0016-02 — On market View →
XELJANZ tofacitinib 1 mg/mL SOLUTION U.S. · NDC 63539-0029-02 · 1 BOTTLE in 1 CARTON (63539-029-02) / 240 mL in 1 BOTTLE (63539-029-01) 63539-0029-02 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.